Journal of Skin and Stem Cell,
Journal Year:
2025,
Volume and Issue:
12(1)
Published: March 28, 2025
Context:
Acne
is
a
prevalent
inflammatory
condition
affecting
individuals
globally,
particularly
during
adolescence,
and
has
significant
psychosocial
impact.
Its
pathogenesis
involves
sebaceous
hypersecretion,
follicular
hyperkeratinization,
microbial
dysbiosis,
primarily
associated
with
Cutibacterium
acnes.
Conventional
acne
treatments,
including
topical
systemic
therapies,
often
cause
adverse
effects,
highlighting
the
need
for
new,
safer
options.
Cannabidiol
(CBD),
non-psychoactive
compound
from
Cannabis
sativa,
emerged
as
promising
candidate
due
to
its
anti-inflammatory
antioxidant
properties.
This
review
discusses
pathophysiology
examines
CBD's
therapeutic
potential
alongside
global
regulatory
perspectives
on
use
in
cosmetics.
Evidence
Acquisition:
A
literature
search
was
conducted
articles
pathogenesis,
endocannabinoid
systems,
pharmacological
effects.
Results:
Acne’s
nature
driven
by
androgen-induced
sebum
production,
imbalance,
mainly
involving
C.
Androgens
activate
receptors
glands,
increasing
production
contributing
pore
blockages
responses.
Although
effective,
conventional
treatments
such
retinoids
antibiotics
have
undesirable
side
driving
interest
plant-based
alternatives.
The
CBD
shows
an
treatment
modulating
inflammation
through
CB2
receptor
TRPV1
channel
activation,
which
directly
helps
reduce
response
that
contributes
severity.
It
also
reduces
sebocyte
proliferation,
addressing
hyperkeratinization
leads
clogged
pores,
inhibits
cytokines
like
TNF-α,
reducing
processes
exacerbate
lesions.
acts
antioxidant,
mitigating
oxidative
stress
acne-related
inflammation.
Furthermore,
CBD’s
lipophilic
facilitates
accumulation
stratum
corneum,
enabling
prolonged
skin
interaction
minimal
absorption.
of
regulations
reveals
varying
levels
acceptance
cosmetics,
North
America
Europe
allowing
under
specific
guidelines,
while
restrictions
remain
stricter
other
regions.
Conclusions:
represents
multi-targeted,
alternative
management,
key
mechanisms
inflammation,
activity,
stress,
without
effects
treatments.
Further
studies
are
necessary
validate
these
findings
clinical
settings
establish
standardized
guidelines
safe
inclusion
skincare
products.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 15, 2023
Cannabis
sativa
,
also
known
as
“hemp”
or
“weed,”
is
a
versatile
plant
with
various
uses
in
medicine,
agriculture,
food,
and
cosmetics.
This
review
attempts
to
evaluate
the
available
literature
on
ecology,
chemical
composition,
phytochemistry,
pharmacology,
traditional
uses,
industrial
toxicology
of
.
So
far,
566
compounds
have
been
isolated
from
including
125
cannabinoids
198
non-cannabinoids.
The
psychoactive
physiologically
active
part
cannabinoid,
mostly
found
flowers,
but
present
smaller
amounts
leaves,
stems,
seeds.
Of
all
phytochemicals,
terpenes
form
largest
composition
plant.
Pharmacological
evidence
reveals
that
plants
contain
which
exhibit
potential
antioxidants,
antibacterial
agents,
anticancer
anti-inflammatory
agents.
Furthermore,
reported
applications
food
cosmetic
industries.
Significantly,
cultivation
has
minimal
negative
impact
environment
terms
cultivation.
Most
studies
focused
make-up,
pharmacological
effects,
not
much
about
toxic
effects.
Overall,
enormous
for
biological
well
other
medicinal
uses.
However,
further
research
necessary
fully
understand
explore
beneficial
properties
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 548 - 548
Published: Jan. 10, 2025
The
sustainable
utilization
of
biomass-derived
bioactives
addresses
the
growing
demand
for
natural
health
products
and
supports
development
goals
by
reducing
reliance
on
synthetic
chemicals
in
healthcare.
Cannabis
sativa
biomass,
particular,
has
emerged
as
a
valuable
resource
within
this
context.
This
study
focuses
hydroethanolic
extract
C.
leaves
(CSE),
which
exhibited
significant
levels
phenolic
compounds
contributing
to
robust
antioxidant
activity.
Evaluation
using
potassium
ferricyanide,
ABTS,
DPPH
methods
revealed
potent
radical
scavenging
activity
comparable
Trolox
standard.
UPLC-MS/MS
profiling
identified
cannabinoids
predominant
secondary
metabolites
CSE,
with
flavonoids
also
present
substantial
quantities.
investigated
anti-inflammatory
potential
CSE
RAW
264.7
macrophages
IL-1β-stimulated
C-20/A4
immortalized
human
chondrocytes,
demonstrating
protective
effects
without
cytotoxic
or
mutagenic
effects.
Mechanistically,
reduced
inflammation
inhibiting
MAPK
NF-κB
signaling
pathways.
In
silico
approaches
showed
ability
CSE's
main
bind
influence
activity,
confirming
vitro
evidence.
Incorporating
leaf
into
hyaluronic
acid-based
formulation
biotechnological
promise
treating
joint
inflammation.
Future
research
should
aim
elucidate
molecular
mechanisms
underlying
these
explore
CSE-derived
mitigating
osteoarthritis
progression.
approach
highlights
significance
utilizing
annually
increasing
biomass
waste
bioactivity
environmental
impact
reduction.
Molecules,
Journal Year:
2022,
Volume and Issue:
28(1), P. 106 - 106
Published: Dec. 23, 2022
The
management
of
orofacial
pain
to
alleviate
the
quality
life
affected
patients
is
becoming
increasingly
challenging
for
scientific
research
and
healthcare
professionals.
From
this
perspective,
in
addition
conventional
therapies,
new
alternatives
are
being
sought,
looking
at
use
both
natural
synthetic
products.
Cannabis
sativa
L.
represents
an
interesting
source
bioactive
compounds,
including
non-psychoactive
cannabinoids,
flavonoids,
terpenes,
many
which
effective
improving
intensity.
Here,
we
aim
analyze
possible
mechanisms
action
hemp-derived
compounds
responsible
modulatory
effects
on
pain-related
pathways.
ability
these
act
multiple
through
a
synergistic
effect,
reducing
release
inflammatory
mediators
regulating
response
endocannabinoid
system,
makes
them
agents
alternative
formulations
be
used
pain.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(10), P. 2049 - 2049
Published: Oct. 18, 2022
In
the
last
few
decades,
endocannabinoids,
plant-derived
cannabinoids
and
synthetic
have
received
growing
interest
as
treatment
options
in
neurodegenerative
conditions.
various
experimental
settings,
they
displayed
antioxidative,
anti-inflammatory,
antiapoptotic,
immunomodulatory,
neuroprotective
effects.
However,
due
to
numerous
targets
downstream
effectors
of
their
action,
cellular
molecular
mechanisms
underlying
these
effects
are
rather
complex
still
under
discussion.
Cannabinoids
able
neutralize
free
radicals
modulate
production
reactive
oxygen
species
activity
antioxidative
systems
acting
on
CB1
CB2
cannabinoid
receptors.
The
activation
receptors
stimulates
signaling
pathways
involved
defense
survival
(such
phosphoinositide
3-kinase
(PI3K)/Akt,
mitogen-activated
protein
kinase
(MAPK),
Nrf2
pathways)
regulates
glutamatergic
signaling,
N-methyl-D-aspartate
(NMDA)
receptors,
calcium
influx,
induction
Ca2+-regulated
cascades,
whereas
mediated
by
suppression
microglial
release
prooxidative
proinflammatory
mediators.
This
review
summarizes
main
new
advances
understanding
cannabinoids.
Because
plethora
possible
pharmacological
interventions
related
oxidative
stress
cannabinoid-mediated
neuroprotection,
future
research
should
be
directed
towards
a
better
interplay
between
activated
signal
transduction
with
aim
improve
efficacy
targeting
endocannabinoid
system.
ChemEngineering,
Journal Year:
2024,
Volume and Issue:
8(4), P. 64 - 64
Published: June 21, 2024
The
increasing
global
focus
on
green
nanotechnology
research
has
spurred
the
development
of
environmentally
and
biologically
safe
applications
for
various
nanomaterials.
Nanotechnology
involves
crafting
diverse
nanoparticles
in
terms
shapes
sizes,
with
a
particular
emphasis
friendly
synthesis
routes.
Among
these,
biogenic
approaches,
including
plant-based
synthesis,
are
favored
their
safety,
simplicity,
sustainability.
Silver
nanoparticles,
particular,
have
garnered
significant
attention
due
to
exceptional
effectiveness,
biocompatibility,
eco-friendliness.
Cannabis
(Cannabis
sativa
L.)
emerged
as
promising
candidate
aiding
silver
nanoparticles.
Leveraging
phytochemical
constituents
Cannabis,
researchers
successfully
tailored
wide
array
applications,
spanning
from
biomedicine
environmental
remediation.
This
review
explores
properties,
mechanisms,
obtained
Cannabis.
Additionally,
it
delves
into
recent
advancements
techniques
elucidates
optical
properties
these
By
shedding
light
fabrication
methods
bionanotechnology
this
aims
contribute
growing
body
knowledge
field
nanotechnology.
Through
comprehensive
examination
processes,
mechanistic
aspects,
potential
underscores
importance
sustainable
approaches
nanoparticle
highlights
Cannabis-derived
addressing
societal
challenges.
Biomolecules,
Journal Year:
2023,
Volume and Issue:
13(12), P. 1725 - 1725
Published: Nov. 30, 2023
Terpenoids
are
the
broadest
and
richest
group
of
chemicals
obtained
from
plants.
These
plant-derived
terpenoids
have
been
extensively
utilized
in
various
industries,
including
food
pharmaceuticals.
Several
specific
identified
isolated
medicinal
plants,
emphasizing
diversity
biosynthesis
functionality
terpenoids.
With
advances
technology
sequencing,
genomes
certain
important
plants
assembled.
This
has
improved
our
knowledge
regulatory
molecular
functions
with
functions.
In
this
review,
we
introduce
several
notable
that
produce
distinct
(e.g.,
Cannabis
sativa,
Artemisia
annua,
Salvia
miltiorrhiza,
Ginkgo
biloba,
Taxus
media).
We
summarize
specialized
roles
these
plant-environment
interactions
as
well
their
significance
pharmaceutical
industries.
Additionally,
highlight
recent
findings
fields
regulation
mechanisms
involved
biosynthesis,
propose
future
opportunities
terpenoid
research,
biology
seeding,
genetic
engineering
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(10), P. 8969 - 8969
Published: May 18, 2023
The
phytochemical
content
and
the
antioxidant
activity
in
inflorescences
of
six
industrial
hemp
(Cannabis
sativa
L.)
genotypes,
four
monoecious
(Codimono,
Carmaleonte,
Futura
75,
Santhica
27),
two
dioecious
(Fibrante
Carmagnola
Selezionata),
were
assessed
for
three
consecutive
years
from
2018
to
2020.
total
phenolic
content,
flavonoid
determined
by
spectrophotometric
measurements,
whereas
HPLC
GC/MS
used
identify
quantify
compounds,
terpenes,
cannabinoids,
tocopherols,
phytosterols.
All
measured
traits
significantly
affected
genotype
(G),
cropping
year
(Y),
their
interaction
(G
×
Y),
although
Y
effect
prevailed
as
a
source
variation,
ranging
50.1%
88.5%
all
metabolites
except
which
equally
G,
Y,
G
(33.9%,
36.5%,
21.4%,
respectively).
genotypes
presented
more
constant
performance
over
compared
with
highest
most
stable
observed
Fibrante,
was
characterized
levels
cannabidiol,
α-humulene
β-caryophyllene,
may
confer
on
this
great
economic
value
due
important
pharmacological
properties
these
metabolites.
Conversely,
27
lowest
accumulation
phytochemicals
years,
notable
exception
cannabigerol,
cannabinoid
that
exhibits
wide
range
biological
activities,
found
at
its
level
genotype.
Overall,
findings
can
be
breeders
future
programs
aimed
selection
new
improved
inflorescences,
provide
better
health
benefits.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(7), P. 1390 - 1390
Published: July 6, 2023
Cannabis
leaves
contain
a
diverse
range
of
antioxidants,
including
cannabinoids,
flavonoids,
and
phenolic
compounds,
which
offer
significant
health
benefits.
Utilising
cannabis
as
source
antioxidants
presents
cost-effective
approach
because
they
are
typically
discarded
during
the
cultivation
plants
for
their
seeds
or
fibres.
Therefore,
this
presented
study
aimed
to
assess
antioxidant
activity
selected
hemp
cultivars,
such
Białobrzeska,
Tygra,
Henola,
based
on
results
obtained
with
2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic
acid,
ferric
reducing
power,
cupric
capacity,
2,2-Diphenyl-1-picrylhydrazyl
assays.
The
cannabinoid
profile
was
analysed
contents
cannabidiol
(CBD),
cannabigerol
(CBG),
Δ9-tetrahydrocannabinol
(Δ9-THC),
cannabichromene
(CBC),
determined
chromatographic
following
variables
were
tested:
impact
various
extractants
(methanol,
ethanol,
isopropanol),
mixtures
(50:50,
v/v,
well
extraction
methods
(maceration
ultra-sound-assisted
extraction)
in
obtaining
extracts
characterised
by
different
profiles.
revealed
that
selection
extractant
conditions
significantly
influenced
active
compounds'
efficiency
activity.
Among
tested
conditions,
ultrasound-assisted
using
methanol
yielded
highest
profile:
CBD
=
184.51
±
5.61;
CBG
6.10
0.21;
Δ9-THC
0.51
0.01;
CBC
0.71
0.01
μg/g
potential
Białobrzeska
leaf
extracts.
Current Issues in Molecular Biology,
Journal Year:
2023,
Volume and Issue:
45(4), P. 3479 - 3514
Published: April 17, 2023
Cannabis
and
related
compounds
have
created
significant
research
interest
as
a
promising
therapy
in
many
disorders.
However,
the
individual
therapeutic
effects
of
cannabinoids
incidence
side
are
still
difficult
to
determine.
Pharmacogenomics
may
provide
answers
questions
concerns
regarding
cannabis/cannabinoid
treatment
help
us
understand
variability
responses
associated
risks.
has
made
meaningful
progress
identifying
genetic
variations
that
play
critical
role
interpatient
response
cannabis.
This
review
classifies
current
knowledge
pharmacogenomics
with
medical
marijuana
can
assist
improving
outcomes
cannabinoid
minimize
adverse
cannabis
use.
Specific
examples
informing
pharmacotherapy
path
personalized
medicine
discussed.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12738 - 12738
Published: Nov. 27, 2024
Cannabis
sativa
L.
contains
numerous
compounds
with
antioxidant
and
anti-inflammatory
properties,
including
the
flavonoids
cannabinoids,
particularly
Δ-9-tetrahydrocannabinol
(THC)
cannabidiol
(CBD).
Cannabinoids
have
an
effect
on
endocannabinoid
system
(ECS),
a
cellular
communication
network,
are,
hence,
widely
studied
for
medical
applications.
Epidiolex®,
99%
pure
oral
CBD
extract,
has
been
approved
by
FDA
treatment
of
epilepsy.
Nabiximols
(Sativex)
is
oromucosal
spray
containing
equal
volume
THC
CBD,
it
commonly
used
as
add-on
unresponsive
spasticity
in
multiple
sclerosis
(MS)
patients.
Several
vitro
vivo
studies
also
shown
that
cannabinoids
can
be
to
treat
various
types
cancer,
such
melanoma
brain
glioblastoma;
first
positive
clinical
trials
anticancer
THC:CBD
blend
temozolomide
(TMZ)
highly
invasive
cancer
are
very
promising.
The
exert
their
properties
investigations
induction
cell
death,
mainly
apoptosis
cytotoxic
autophagy,
inhibition
proliferation.
In
several
studies,
found
induce
tumor
regression
inhibit
angiogenic
mechanisms
vivo,
well
two
low-numbered
epidemiological
studies.
They
exhibit
antiviral
effects
inhibiting
ACE2
transcription,
blocking
viral
replication
fusion,
acting
agents;
indeed,
prior
consumption
(a
study
93,565
persons
Chicago)
associated
much
lower
incidence
SARS-CoV-2
infections.
It
postulated
cannabis
extracts
many
other
diseases
systemic
lupus
erythematosus,
type
1
diabetes,
or
neurological
disorders,
e.g.,
Alzheimer’s
disease.
aim
this
review
outline
current
state
knowledge
regarding
currently
medicinal
preparations
derived
from
C.
selected
diseases,
present
latest
research
potential
applications
its
secondary
metabolites.